13160-59-3

Basic information

• Product Name: 4-AMINO-N-PYRIDIN-3-YLBENZAMIDE
• Synonyms: 4-AMINO-N-PYRIDIN-3-YLBENZAMIDE;4-AMINO-N-3-PYRIDINYLBENZAMIDE;AKOS BBV-011304;4-amino-N-3-pyridinylbenzamide(SALTDATA: FREE)
• CAS NO: 13160-59-3
• Molecular Formula: C₁₂H₁₁N₃O
• Molecular Weight: 213.24
• Mol File: 13160-59-3.mol
• Article Data: 3

Chemical Properties

• Boiling Point: 342.9°C at 760 mmHg
• Flash Point: 161.2°C
• Appearance: /
• Density: 1.301g/cm³
• Vapor Pressure: 7.29E-05mmHg at 25°C
• Refractive Index: 1.697
• CAS DataBase Reference: 4-AMINO-N-PYRIDIN-3-YLBENZAMIDE(CAS DataBase Reference)
• NIST Chemistry Reference: 4-AMINO-N-PYRIDIN-3-YLBENZAMIDE(13160-59-3)
• EPA Substance Registry System: 4-AMINO-N-PYRIDIN-3-YLBENZAMIDE(13160-59-3)

Safety Data

• Hazardous Substances Data: 13160-59-3(Hazardous Substances Data)

Usage

InChI:InChI=1/C12H11N3O/c13-10-5-3-9(4-6-10)12(16)15-11-2-1-7-14-8-11/h1-8H,13H2,(H,15,16)

Upstream product

• 66493-39-8 4-(N-tert-butoxycarbonyl)aminobenzoic acid 
• 462-08-8 pyridin-3-ylamine 
• 1326565-88-1 C₁₇H₁₉N₃O₃ 
• 13313-18-3 4-nitro-N-(pyridin-3-yl)benzamide 

Downstream Products

• 909504-92-3 C₁₉H₁₅N₃O₂ 
• 1552311-69-9 C₂₀H₁₇N₃O₂ 
• 1552311-71-3 C₁₉H₁₄ClN₃O₂ 
• 1552311-74-6 C₂₃H₂₃N₃O₂ 
• 831214-35-8 C₁₃H₁₃N₃O₃S 
• 838260-50-7 C₁₈H₁₅N₃O₃S 
• 831204-81-0 C₁₉H₁₇N₃O₃S 
• 1552311-73-5 C₁₈H₁₄ClN₃O₃S 
• 1552311-75-7 C₂₂H₂₃N₃O₃S 
• 1229653-23-9 C₂₀H₁₅F₃N₄O₂ 
• 1173207-71-0 4-({[4-(3-ethyl-7-morpholin-4-yl-3H-[1,2,3]triazolo[4,5-d]pyrimidin-5-yl)phenyl]carbamoyl}amino)-N-pyridin-3-ylbenzamide 

Relevant articles and documents

Towards the development of non-enediyne approaches for mimicking enediyne chemistry: Design, synthesis and activity of a 1,4-bisdiazonium compound

1,4-bisdiazonium compounds, whichmay be precursors of aryl 1,4-diradicals, have the potential to mimic the DNA cleaving activity of the enediyne antibiotics. To this end, the ability to generate and activate 1,4-bisdiazonium compounds in good yield (e.g.,

Exploration of secondary and tertiary pharmacophores in unsymmetrical N,N′-diaryl urea inhibitors of soluble epoxide hydrolase

The impact of various secondary and tertiary pharmacophores on in vitro potency of soluble epoxide hydrolase (sEH) inhibitors based on the unsymmetrical urea scaffold 1 is discussed. N,N′-Diaryl urea inhibitors of soluble epoxide hydrolase exhibit subtle variations in inhibitory potency depending on the secondary pharmacophore but tolerate considerable structural variation in the second linker/tertiary pharmacophore fragment.